C12Y 204/01018
1,4-alpha-glucan branching enzyme , i.e. glucan branching enzyme
Official title: 1,4-Alpha-glucan branching enzyme (2.4.1.18), i.e. glucan branching enzyme
C12Y204/01018 (1,4-alpha-glucan branching enzyme , i.e. glucan branching enzyme) appears on 24 US grants and 35 published applications in this corpus.
Search patents in C12Y- Granted patents
- 24
- Published applications
- 35
- Assignees
- 19
- Inventors
- 78
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 2 | 1 |
| 2012 | 1 | 0 |
| 2013 | 0 | 3 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 2 | 2 |
| 2017 | 1 | 4 |
| 2018 | 0 | 2 |
| 2019 | 3 | 2 |
| 2020 | 2 | 0 |
| 2021 | 2 | 4 |
| 2022 | 0 | 1 |
| 2023 | 3 | 5 |
| 2024 | 0 | 4 |
| 2025 | 1 | 2 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Enzymatic production of allulose15 Sep 2026US 12,735,685 B2Bonumose, Inc.
- Converted starch and food comprising said converted starch14 Apr 2026US 12,600,802 B2Sveriges StäRkelseproducenter, FöRening U.P.A.
- Wheat with increased resistant starch levels3 Jun 2025US 12,319,920 B2Arcadia Biosciences, Inc.
- High amylose wheat with undetectable levels of SBEIIa protein29 Aug 2023US 11,737,482 B2Arista Cereal Technologies Pty Limited
- Wheat with increased resistant starch levels16 May 2023US 11,649,464 B2Arcadia Biosciences, Inc.
- Method for the enzymatic production of soluble fibres7 May 2026US 2026/0125726 A1Roquette Freres
- Wheat with increased resistant starch levels30 Oct 2025US 2025/0333755 A1Arcadia Biosciences, Inc.
- Compositions and methods for treating and/or preventing glycogen storage diseases12 Jun 2025US 2025/0186618 A1Duke University
- Treatment Of Stroke With 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Inhibitors25 Jul 2024US 2024/0247267 A1Regeneron Pharmaceuticals, Inc.
- Resistant-isomalto-oligosaccharide (imo-r)11 Jul 2024US 2024/0229092 A1
Most cited
By later US patents
- Antisense intron inhibition of starch branching enzyme expression34US 6,483,009 B1Danisco A/S · 2002
- Polypeptides having branching enzyme activity and nucleic acids encoding same14US 6,608,018 B1Novozymes A/S · 2003
- High amylose wheat-II10US 9,357,722 B2Arista Cereal Technologies Pty Limited · 2016
- Inhibition of gene expression6US 6,147,279 ADanisco A/S · 2000
- Wheat with increased resistant starch levels5US 10,246,716 B2Arcadia Biosciences, Inc. · 2019